<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JAMP</journal-id><journal-title-group><journal-title>Journal of Applied Mathematics and Physics</journal-title></journal-title-group><issn pub-type="epub">2327-4352</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jamp.2016.41010</article-id><article-id pub-id-type="publisher-id">JAMP-62778</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Physics&amp;Mathematics</subject></subj-group></article-categories><title-group><article-title>
 
 
  Mathematical Study of the Dynamics of the Development of HIV
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>abriel</surname><given-names>Iyam Ogban</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Konstantin</surname><given-names>Andreyevich Lebedev</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Department of Computational Mathematics and Informatics, Kuban State University, Krasnodar, Russia</addr-line></aff><author-notes><corresp id="cor1">* E-mail:<email>gabogban@yahoo.com(AIO)</email>;<email>klebedev.ya@yandex.ru(KAL)</email>;</corresp></author-notes><pub-date pub-type="epub"><day>11</day><month>01</month><year>2016</year></pub-date><volume>04</volume><issue>01</issue><fpage>66</fpage><lpage>72</lpage><history><date date-type="received"><day>18</day>	<month>November</month>	<year>2015</year></date><date date-type="rev-recd"><day>accepted</day>	<month>12</month>	<year>January</year>	</date><date date-type="accepted"><day>15</day>	<month>January</month>	<year>2016</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Over the history of humankind, they is no disease that has received so much attention as the HIV infection and mathematical models have been applied successfully to the investigation of HIV dynamics. It is, however, of note that, few of these investigations are able to explain the observation that host cell counts reduce while viral load increases as the infection progress. Also, various clinical studies of HIV infection have suggested that high T-cell activation levels are positively correlated with rapid disease development in untreated patients. This activation might be a major reason for the depletion of cells observed in most cases of long-term untreated HIV infection. In this paper, we use a simple mathematical model without treatment to investigate the stability of the system and compare the results with that obtained numerically by the use of MATHCAD. Our model which is a system of differential equations describing the interaction of the HIV and the immune system is divided into three compartments: uninfected CD4T cells, infected CD4Tcells and the virus population. This third compartment includes an extra source of the virus since it is believed that the virus in the blood constitute less than 2% of the total population. We obtain a linearization of the original system, and using Routh-Hurwitz condition for the non-linear system, the critical points are unstable.
 
</p></abstract><kwd-group><kwd>Model</kwd><kwd> HIV</kwd><kwd> CD4+T Cell</kwd><kwd> Infected Cell</kwd><kwd> Uninfected Cell</kwd><kwd> Stability</kwd><kwd> Linearization</kwd><kwd> Equilibrium</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>The selective depletion of CD4<sup>+</sup>T cells, the cells commonly known as helper T cells or T4 cells by the human immunodeficiency virus (HIV) is the cause of infection in human and has been the subject of most intense studies that encompass diverse field of scientific studies. HIV infect CD4<sup>+</sup>T cells which play a central role in immune regulation and their depletion can have widespread deleterious effects on the functioning of the immune system as a whole, this is cause for alarm and a key reason for HIV devastating effect [<xref ref-type="bibr" rid="scirp.62778-ref1">1</xref>] . Indeed, the decline in the number of CD4<sup>+</sup>T cells in peripheral blood is used in a clinical setting as an indicator of the disease stage [<xref ref-type="bibr" rid="scirp.62778-ref2">2</xref>] . The puzzle today is that while much progress has been achieved by medical and biological researchers in understanding aspect of the virus-host interaction, the mechanism by which HIV causes AIDS still remains unexplained.</p><p>The dynamics of immune response to any virus involves different components and is generated by a complex web of interactions among different types of white blood cells (monocytes, T and B cells). Although they can be variations from one patient to another, the time scale to develop a specific immune response may vary from days to weeks. In the case of HIV, the entire course of infection involves two different time scales [<xref ref-type="bibr" rid="scirp.62778-ref3">3</xref>] . The primary infection which shares many similarities with acute infections, exhibits the same characteristics as any other viral infection: a dramatic increase of the virus population during the first 3 - 6 weeks, followed by a sharp decline, due to the action of the immune system. Instead of being completely eliminated after the primary infection, as many other viruses, however, a low HIV concentration is detected for a long asymptomatic time: the clinical latency period. During this period, the immune response keeps the viral load to a constant level referred to as the set point viral load [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] . This period may vary from one to ten (or more) years [<xref ref-type="bibr" rid="scirp.62778-ref5">5</xref>] . Besides the low virus burden detected during this period, a gradual deterioration of the immune system is manifested by the reduction of CD4<sup>+</sup>T cell populations in the peripheral blood. The third phase of the disease is achieved when the concentration of the T cells is lower than a critical value (~30%), leading to the development of AIDS.</p><p>Differential equations represent good approximations to situations where there are large number of events happening on average and when the time scale over which the average is being examined is much longer than the interval between events. At the initial time when the research into HIV/AIDS started, it was not understood that in HIV-infected individuals the virus was being produced at a prolific rate even before the onset of symptoms and full-blown AIDS. Mathematical models have been proven valuable in understanding the dynamics of HIV infection. Perelson and Nelson [<xref ref-type="bibr" rid="scirp.62778-ref5">5</xref>] developed a simple model for the primary infection with HIV. This model has been important in the field of mathematical modeling of HIV infection, and many other models have been proposed, which take this model as their inspiration. Perelson et al. [<xref ref-type="bibr" rid="scirp.62778-ref6">6</xref>] extended the model in 1993 and discussed some of the model's behavior. They defined the model by considering four categories: uninfected CD4<sup>+</sup>T cells, latently infected CD4<sup>+</sup>T cells, productively infected CD4<sup>+</sup>T cells and virus population. Wodarz and Nowak [<xref ref-type="bibr" rid="scirp.62778-ref7">7</xref>] used their model to measure crucial parameters which led to a new understanding of the disease process. Furthermore, in their work they showed how mathematical models can be used to understand correlates of long-term immunological control of HIV, and to design therapy regimes that convert a progressing patient into a state of long-term non-progression. Shi, V. et al. [<xref ref-type="bibr" rid="scirp.62778-ref8">8</xref>] formulated a novel cellular automated (CA) model for HIV dynamics and drug treatment. The model is built upon realistic biological processes, including the virus replication cycle and mechanism of drug therapy. Viral load, its effect on infection rate, and the role of latently infected cells in sustaining HIV infection are among the aspects that are explored and incorporated in the model. The results of the simulation show the three phases of HIV dynamics. In the rest of what follows, we introduce our mathematical model of HIV without treatment in Section 2. In Section 3, we introduce a linearization technique. Section 4 deals with the numerical simulation and analysis. The last section is the conclusion.</p>Statement of Problem<p>Nonlinearity can be classified as inherent (natural) and intentional (artificial). The case of interaction of HIV with the immune system is one that has undesirable effects; control and eradication have been of increasing concern to clinicians and mathematical modellers. The behaviour of this nonlinear system, however, is much more complex as HIV evolves and behaves differently from other viruses. Can there then be any equilibrium point?</p></sec><sec id="s2"><title>2. HIV Model without Treatment</title><p>We consider the model developed by Kirschner, D and Webb [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] , in which Pritikin [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] obtained a numerical solution showing the course of HIV. Ogban and Lebedev [<xref ref-type="bibr" rid="scirp.62778-ref10">10</xref>] carried out numerical stability of [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] . The objective here is to seek physical stability (analytic solution) to the system. Linearizing the system, we compare our analytic solution with the numerical solution obtained in [<xref ref-type="bibr" rid="scirp.62778-ref10">10</xref>] . We introduce a system of ordinary differential equations modeling the immune dynamics of an HIV infected immune system in the absence of treatment. The variables are defined as follows:</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x6.png" xlink:type="simple"/></inline-formula>―Concentration of uninfected CD4<sup>+</sup>T cells;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x7.png" xlink:type="simple"/></inline-formula>―The concentration of CD4<sup>+</sup>T cells infected with HIV;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x8.png" xlink:type="simple"/></inline-formula>―Concentration of HIV virus.</p><p>We note that the model without treatment describes the processes in the blood, the replication of the virus and mortality of cells occurring in the lymphatic system, and as a result, the model describes the dynamics observed in the blood variables rather than operating characteristics of infection.</p><p>The derivatives with respect to time of these variables satisfy the system of differential equations:</p><disp-formula id="scirp.62778-formula545"><label>(1)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x9.png"  xlink:type="simple"/></disp-formula><p>The system of equation has the initial conditions:</p><disp-formula id="scirp.62778-formula546"><graphic  xlink:href="http://html.scirp.org/file/4-1720453x10.png"  xlink:type="simple"/></disp-formula><p>The expressions on the right sides of Equations (1)-(3) indicate the following: In Equation (1), <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x11.png" xlink:type="simple"/></inline-formula>is a function, which represents the source of, uninfected CD4<sup>+</sup>T-cells from the thymus</p><p>and other compartments. Here <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x12.png" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x13.png" xlink:type="simple"/></inline-formula> are constants, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x14.png" xlink:type="simple"/></inline-formula>is a saturation constant (saturation ratios introduced into the model to adjust the parameters of growth under great changes in populations during the course</p><p>of infection and treatment). m-is the mortality rate of uninfected CD4<sup>+</sup>T-cells (birth rate =<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x15.png" xlink:type="simple"/></inline-formula>); <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x16.png" xlink:type="simple"/></inline-formula> where <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x17.png" xlink:type="simple"/></inline-formula> and C describes the proliferation rate of CD4<sup>+</sup>T-cells in the plasma</p><p>eliciting an immune response, due to the effect of stimulating the immune system antigen; this explains the increased turnover member of CD4<sup>+</sup>T-cells;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x18.png" xlink:type="simple"/></inline-formula>―is the infection rate of CD4<sup>+</sup>T-cells by the virus.</p><p>In Equation (2):<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x19.png" xlink:type="simple"/></inline-formula>―the growth rate of infected CD4<sup>+</sup>T-cells as the virus infects T-cells;<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x20.png" xlink:type="simple"/></inline-formula>― a loss due to mortality of the infected cells;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x21.png" xlink:type="simple"/></inline-formula>where <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x21.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x22.png" xlink:type="simple"/></inline-formula> is a saturation coefficient describes the death of infected cells owing to the presence of the virus.</p><p>In Equation (3): The virus population increases due to the term <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x23.png" xlink:type="simple"/></inline-formula> where <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x24.png" xlink:type="simple"/></inline-formula> this term describes the increase in the population of virus in the blood. The dependence of this term on <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x23.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x24.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x25.png" xlink:type="simple"/></inline-formula></p><p>takes into account the reduction in the proliferation of the virus in the plasma when the concentration of infected CD4<sup>+</sup>T cells in the plasma decreases. Since most virus enters into the plasma from the external source of lymph, the plasma viral population during the final stage of the infection grows rapidly; <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x26.png" xlink:type="simple"/></inline-formula>-describes the</p><p>destruction of the virus by the immune system; <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x27.png" xlink:type="simple"/></inline-formula>(where B saturation constant) takes into</p><p>account the entry of the virus from the lymphoid system. This term is a major contributor to the population of virus in the blood. The parameter values are as given in <xref ref-type="table" rid="table1">Table 1</xref>, see [<xref ref-type="bibr" rid="scirp.62778-ref10">10</xref>] .</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> List of constants and parameters</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Symbol</th><th align="center" valign="middle" >Description</th><th align="center" valign="middle" >Value</th></tr></thead><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x28.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Mortality rate of uninfected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >0.005/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x29.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Mortality rate of infected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >0.25/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x30.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The rate at which CD4<sup>+</sup>T cells are infected by sensitive virus</td><td align="center" valign="middle" >0.0005 mm<sup>3</sup>/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x31.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The rate at which CD4<sup>+</sup>T cells are affected by resistant virus</td><td align="center" valign="middle" >0.0005 mm<sup>3</sup>/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x32.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Loss of virus caused by immune response</td><td align="center" valign="middle" >0.0062 mm<sup>3</sup>/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x33.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The rate of reproduction of uninfected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >0.025/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x34.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The rate of reproduction of infected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >0.25/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x35.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The rate of reproduction of virus in the blood</td><td align="center" valign="middle" >0.8/day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x36.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >External parameter of lymphoid sensitivity virus</td><td align="center" valign="middle" >41.2 mm<sup>3</sup>/day</td></tr><tr><td align="center" valign="middle" >q</td><td align="center" valign="middle" >External parameter of lymphoid resistivity virus</td><td align="center" valign="middle" >41.2 mm<sup>3</sup>/day</td></tr><tr><td align="center" valign="middle" >C</td><td align="center" valign="middle" >Threshold resistance</td><td align="center" valign="middle" >0.5/mm<sup>3</sup></td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x37.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >The proportion of resistance virus obtained as a result of normal reproduction of virus</td><td align="center" valign="middle" >10<sup>-7</sup></td></tr><tr><td align="center" valign="middle" >B</td><td align="center" valign="middle" >Saturation ratio of uninfected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >47.0/mm<sup>3</sup></td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x38.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Saturation ratio of infected CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >47.0/mm<sup>3</sup></td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x39.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Saturation ratio of external virus source</td><td align="center" valign="middle" >2.0/mm<sup>3</sup></td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x40.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Saturation ratio of CD4<sup>+</sup>T cell source</td><td align="center" valign="middle" >13.8/mm<sup>3</sup></td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x41.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Influx of CD4<sup>+</sup>T cells in the absence of virus</td><td align="center" valign="middle" >4.0 mm<sup>3</sup>day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x42.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Decrease of influx of CD4<sup>+</sup>T cells</td><td align="center" valign="middle" >2.8 mm<sup>3</sup>day</td></tr><tr><td align="center" valign="middle" ><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x43.png" xlink:type="simple"/></inline-formula></td><td align="center" valign="middle" >Treatment parameter inhibiting the rate of distribution of CD4<sup>+</sup>T cells by the virus</td><td align="center" valign="middle" >0.5</td></tr></tbody></table></table-wrap></sec><sec id="s3"><title>3. Linearization Technique</title><p>The similarity of a nonlinear system to a linear system in the local region of each singular point can be formalized by linearizing the nonlinear system as we now discuss.</p><p>If the singular point of interest is not the origin, by defining the difference between the original state and the singular point as a new set of variables, one can shift the singular point to the origin. Therefore, without loss of generality, we may simply consider Equation (1) with a singular point (0, 0, and 0) [<xref ref-type="bibr" rid="scirp.62778-ref6">6</xref>] . Thus (1a-c) can be rewritten as a system</p><disp-formula id="scirp.62778-formula547"><label>(2)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x44.png"  xlink:type="simple"/></disp-formula><p>We can write (2a-c) as</p><disp-formula id="scirp.62778-formula548"><label>(3)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x45.png"  xlink:type="simple"/></disp-formula><p>where<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x46.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x46.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x47.png" xlink:type="simple"/></inline-formula>,<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x46.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x47.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x48.png" xlink:type="simple"/></inline-formula>.</p><p>Thus, if we write</p><disp-formula id="scirp.62778-formula549"><label>(4)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x49.png"  xlink:type="simple"/></disp-formula><p>where (3) is equal to (4) if g(t) is neglected. By [<xref ref-type="bibr" rid="scirp.62778-ref11">11</xref>] , the nonlinear system (3) is a perturbation of the associated linear system (4). Now for system (2) the Jacobian matrix is given as</p><disp-formula id="scirp.62778-formula550"><label>(5)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x50.png"  xlink:type="simple"/></disp-formula><p>We find that this system has one equilibrium point<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x51.png" xlink:type="simple"/></inline-formula>. The Jacobian at the fixed point <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x51.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x52.png" xlink:type="simple"/></inline-formula> is</p><disp-formula id="scirp.62778-formula551"><label>(6)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x53.png"  xlink:type="simple"/></disp-formula><p>The characteristic equation of (6) is given by</p><disp-formula id="scirp.62778-formula552"><label>(7)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x54.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.62778-formula553"><label>(8)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/4-1720453x55.png"  xlink:type="simple"/></disp-formula><p>Since the system is three-dimensional, we use the Routh-Hurwitz criterion to establish the negativity of the real parts of the roots of the characteristic equation and therefore stability of the equilibrium under consideration. For a three-dimensional system see [<xref ref-type="bibr" rid="scirp.62778-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref13">13</xref>] , with a characteristic equation of the form:</p><disp-formula id="scirp.62778-formula554"><graphic  xlink:href="http://html.scirp.org/file/4-1720453x56.png"  xlink:type="simple"/></disp-formula><p>The Routh-Hurwitz criteria state that all roots of the characteristic equation have negative parts (local stability) if and only if <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x57.png" xlink:type="simple"/></inline-formula></p><p>Analysis of the characteristic equation evaluated at the fixed point, shows that it is unstable. It is however stable if<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x58.png" xlink:type="simple"/></inline-formula>.</p></sec><sec id="s4"><title>4. Numerical Simulation and Analysis</title><p>Using MathCAD, we employed Runge Kuta method of order 4 to obtain our simulations. It has been reported that during acute infection the individual become antigenic and viremic. High levels of infectious virus can be detected in the peripheral blood [<xref ref-type="bibr" rid="scirp.62778-ref14">14</xref>] . With the initial conditions as given above, we investigate the influence of the viral reproduction rate on the three variables. Our calculations with the same initial conditions are shown to be consistent with results from the authors in [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] . This fact validates our computational work with the models which are without treatment in [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] . In [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] , they showed that remission depended on a certain threshold of the virus level.</p><p>Figures 1-3 are the numerical solutions to Model 1. The parameter values used to generate these figures can be found in <xref ref-type="table" rid="table1">Table 1</xref> [<xref ref-type="bibr" rid="scirp.62778-ref10">10</xref>] . The simulations of the dynamics are with T(0) = 600/mm<sup>3</sup>, T<sub>s</sub>(0) = 0, V<sub>s</sub>(0) = 10. The viral reproduction rates are: <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x59.png" xlink:type="simple"/></inline-formula>and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x59.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x60.png" xlink:type="simple"/></inline-formula> Noting that the model is without treatment, if the parameter value is kept very low then it takes longer time for the level of T-cells to get lower than 200/mm<sup>3</sup>. This means that a low value of the parameter does not push the system into the progression to AIDS. In other words, the steep crash in day 3000 takes longer to achieve. This suggests that with low levels reproduction of virus the infection may go extinct rather than take off, see [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref10">10</xref>] . Complete inhibition of viral replication appears</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Graphical simulations of uninfected CD4<sup>+</sup>T cells against time</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-1720453x61.png"/></fig><fig id="fig2"  position="float"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Graphical simulations of infected T cells against time</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-1720453x62.png"/></fig><fig id="fig3"  position="float"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Graphical simulations of virus cells against time</title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/4-1720453x63.png"/></fig><p>impossible and may be unnecessary. In Figures 1-3, the curves <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x64.png" xlink:type="simple"/></inline-formula> represent the values <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x64.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x65.png" xlink:type="simple"/></inline-formula> and <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x64.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x65.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x66.png" xlink:type="simple"/></inline-formula> respectively.</p><p>As shown in [<xref ref-type="bibr" rid="scirp.62778-ref4">4</xref>] , the curves of Figures 1-3 are consistent with the results of clinical trials of HIV [<xref ref-type="bibr" rid="scirp.62778-ref15">15</xref>] - [<xref ref-type="bibr" rid="scirp.62778-ref18">18</xref>] . After a period of acute infection during the first few weeks after seroconversion, the number of CD4<sup>+</sup>T cells gradually decline from approximately from <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula> to zero over a period of time equal to approximately 10 years (normal number of CD4<sup>+</sup>T cells varies in the range of<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x68.png" xlink:type="simple"/></inline-formula>) [<xref ref-type="bibr" rid="scirp.62778-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.62778-ref17">17</xref>] . The decline of T is more rapid in the early stage of infection [<xref ref-type="bibr" rid="scirp.62778-ref16">16</xref>] (wherein infected CD4<sup>+</sup>T cells <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x68.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x69.png" xlink:type="simple"/></inline-formula> constitute up to 4% of the total number of CD4<sup>+</sup>T cells T [<xref ref-type="bibr" rid="scirp.62778-ref14">14</xref>] ). The life expectancy of infected CD4<sup>+</sup>T <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x68.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x69.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x70.png" xlink:type="simple"/></inline-formula> cells is approximately equal to two days [<xref ref-type="bibr" rid="scirp.62778-ref18">18</xref>] . After an initial period of acute infection, virus increases from below <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x68.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x69.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x70.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x71.png" xlink:type="simple"/></inline-formula> to <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x67.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x68.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x69.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x70.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x71.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/4-1720453x72.png" xlink:type="simple"/></inline-formula> or more during the variable course of infection with a sharp increase towards the end of the symptomatic phase [<xref ref-type="bibr" rid="scirp.62778-ref15">15</xref>] . The life span of a virus outside the cell is about 7.2 hours [<xref ref-type="bibr" rid="scirp.62778-ref18">18</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Mathematical modeling of the dynamics of the development of HIV in the immune system has led to a number of important insights about the dynamics and pathogenesis of HIV infection. A dynamical model of the interaction of HIV and the immune system was presented. We have tried to demonstrate how mathematical modeling can help us to understand HIV pathogenesis. We obtained the solution of the system both analytically and numerically. We applied perturbation and stability theory to obtain our analytic results. Our numerical results are consistent with typical clinical course of HIV infection.</p></sec><sec id="s6"><title>Cite this paper</title><p>Gabriel IyamOgban,Konstantin AndreyevichLebedev, (2016) Mathematical Study of the Dynamics of the Development of HIV. Journal of Applied Mathematics and Physics,04,66-72. doi: 10.4236/jamp.2016.41010</p></sec></body><back><ref-list><title>References</title><ref id="scirp.62778-ref1"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kirschner</surname><given-names> D. </given-names></name>,<etal>et al</etal>. (<year>1996</year>)<article-title>Using Mathematics to Understand HIV Immune Dynamics</article-title><source> Notice of the AMS</source><volume> 43</volume>,<fpage> 191</fpage>-<lpage>202</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.62778-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">CD4 (2015). https://en.wikipedia.org/wiki/CD4</mixed-citation></ref><ref id="scirp.62778-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Time between Initial HIV Infection and AIDS Is not Symptom-Free (2009).http:www.thebodypro.com/content/art51231.html</mixed-citation></ref><ref id="scirp.62778-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Kirschner, D. and Webb, G.F. (1997) Resistance, Remission, and Qualitative Difference in HIV Chemotherapy. Emerging Infectious Diseases, 3, 273-283. http://dx.doi.org/10.3201/eid0303.970303</mixed-citation></ref><ref id="scirp.62778-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Perelson, A.S. and Nelson, P.W. (1999) Mathematical Analysis of HIV-1 Dynamics in Vivo. SIAM, 41, 3-44. http://dx.doi.org/10.1137/S0036144598335107</mixed-citation></ref><ref id="scirp.62778-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Perelson A.S, Kirschner D.E. and Boer, R.D. (1993) Dynamics of HIV infection of CD4+T Cells. Mathematical Biosciences, 114, 81-125. http://dx.doi.org/10.1016/0025-5564(93)90043-A</mixed-citation></ref><ref id="scirp.62778-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Wodarz, D. and Nowak, A. (2002) Mathematical Model of HIV Pathogenesis and Treatment. Bioessays, 24, 1178-1187. http://dx.doi.org/10.1002/bies.10196</mixed-citation></ref><ref id="scirp.62778-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Shi, V., Trdane, A. and Kung, Y.A. (2008) Viral Load Based Cellular Automated Approach to Modeling HIV Dynamics and Drug Treatment. Journal of Theoretical Biology, 253, 24-35. http://dx.doi.org/10.1016/j.jtbi.2007.11.005</mixed-citation></ref><ref id="scirp.62778-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Pritikin, D.A. (2007) Optimal Control Mathematical Model of HIV Infection. Thesis for Scientific Degree of Candidate of Physical and Mathematical Sciences. Moscow, 110.</mixed-citation></ref><ref id="scirp.62778-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Ogban, G.I. and Lebedev, K.A. (2015) Mathematical Model of the Dynamics of HIV Infection without Treatment. Polytheistic Online Scientific Journal of Kuban State Agrarian University [Electronic Resource], No. 110.http://ej.kubagro.ru/2015/06/pdf/38.pdf</mixed-citation></ref><ref id="scirp.62778-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Hale, J.K. (1969) Ordinary Differential Equations. New York.</mixed-citation></ref><ref id="scirp.62778-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Jean-Jacques, E.S. and Weiping, L. (1991) Applied Nonlinear Control. New Jersey.</mixed-citation></ref><ref id="scirp.62778-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Routh-Hurwitz Stability Criterion (2009). https://en.wikipedia.org/wiki/Routh-Hurwitz_stability_criterion</mixed-citation></ref><ref id="scirp.62778-ref14"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Levy</surname><given-names> J.A. </given-names></name>,<etal>et al</etal>. (<year>1993</year>)<article-title>Pathogenesis of Human Immunodeficiency Virus Infection</article-title><source> MMBR</source><volume> 57</volume>,<fpage> 183</fpage>-<lpage>289</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.62778-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Pennisi, E. and Cohen, J. (1996) Eradicating HIV from a Patient: Not Just a Dream? Science, 272, 1884. http://dx.doi.org/10.1126/science.272.5270.1884</mixed-citation></ref><ref id="scirp.62778-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Philips, A.N., Sabin, C.A., Miocroft, A., et al. (1995) Antiviral Therapy. Nature, 375, 195. http://dx.doi.org/10.1038/375195a0</mixed-citation></ref><ref id="scirp.62778-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Pokrovsky, V.V., Ermak, N., Belyaeva, V.V. and Yurt, E.G. (2000) HIV Infection. The Clinic, Diagnoses and Treatment. Geotar Medicine.</mixed-citation></ref><ref id="scirp.62778-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Perelson, A., Neumann, A., Markowitz, M., et al. (1996) HIV-1 Dynamics in Vivo: Clearance Rate, Infected Cell Lifespan, and Viral Generation Time. Science, 271, 1582-1586. http://dx.doi.org/10.1126/science.271.5255.1582</mixed-citation></ref></ref-list></back></article>